BioNexus Gene Lab Corp. (NASDAQ:BGLC) Sees Significant Growth in Short Interest

BioNexus Gene Lab Corp. (NASDAQ:BGLC) was the target of a large growth in short interest in December. As of December 15th, there was short interest totalling 197,100 shares, a growth of 164.6% from the November 30th total of 74,500 shares. Currently, 1.7% of the company’s stock are sold short. Based on an average daily volume of 602,900 shares, the short-interest ratio is currently 0.3 days.

BioNexus Gene Lab Price Performance

Shares of BioNexus Gene Lab stock opened at $0.27 on Friday. BioNexus Gene Lab has a 52-week low of $0.21 and a 52-week high of $3.39. The business’s 50 day simple moving average is $0.31 and its 200 day simple moving average is $0.40.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.